Collaborating with Us
Hematologic Malignancies | Stem Cell Transplantation
One of our top priorities is to collaborate with our referring providers to ensure that our shared patients have access to care across the entire continuum of services they need in the most appropriate and convenient location for them during the course
of their treatment. Through partnering with you, we can help your patients receive their care closer to home, reducing the time and cost of care without sacrificing quality.
About Our Hematologic Malignancies Program
Treating Blood Cancers and Related Disorders
In partnership with referring physicians, the
Hematologic Malignancies program at Dana-Farber/Brigham and Women's Cancer Center provides highly specialized care for patients with all types of blood cancers – including leukemia, lymphoma, multiple
myeloma, and Waldenström's macroglobulinemia (WM) – as well as related blood disorders, such as aplastic anemia and myelodysplasia. Our program combines the clinical expertise, focus, and innovation of one of the world's leading cancer centers with
expert care and services of one of the nation's leading hospitals.
In addition to next-day patient access, we offer physician-to-physician consults within 24 hours.
See our quick access reference
Our Treatment Centers
Adult Leukemia Program
Chronic Lymphocytic Leukemia Program
Multiple Myeloma Program
Bing Center for Waldenström's Macroglobulinemia
Our Specialized Programs
Hematopoietic Stem Cell/Bone Marrow Transplant (HSCT) Program
Cellular Therapies Program
Adult Histiocyte Disorders Center
BPDCN Center (Blastic Plasmacytoid Dendritic Cell Neoplasm)
Center for Prevention of Progression
Older Adult Hematologic Malignancy (OHM) Program
Blood Cancer Research Partnership (BCRP)
Our Treatment Team
Our Shared Care Pocket Directory contains contact information for all members of Dana-Farber/Brigham and Women's Cancer Center's (DFCC) disease-specific administrative and clinical team. Order a copy by calling 617-632-3069.
Clinical Trials and Research
More than 100 innovative clinical trials are currently underway in the Center for Hematologic Oncology — offering new avenues of treatment for upfront and recurrent disease. The combined resources of our partner organizations within Dana-Farber/Harvard
Cancer Center make us the largest cancer research center in the nation. Search current hematologic cancer and blood disorders clinical trials, or call our disease-specific blood cancer specialists at 617-632-7202.
Learn about our comprehensive array of
clinical and support resources for your patients.
stem cell transplant resources for referrers and payers.
Download our Stem Cell Transplant and Cellular Therapies Guide.